SCHEMBL6405467

SCHEMBL6405467

Clc1cccc(Cl)c1CSc1nnc(-c2ccncc2)n1-c1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 4/20 0.64
CYP3A4 P08684 1/20 0.61
CYP2C9 P11712 1/20 0.61
LMNA P02545 3/20 0.59
HTT P42858 2/20 0.59
HDAC2 Q92769 3/20 0.56
HDAC3 O15379 2/20 0.56
HDAC1 Q13547 2/20 0.56
HDAC8 Q9BY41 2/20 0.56
HDAC6 Q9UBN7 2/20 0.56
MAPT P10636 3/20 0.55
TACR1 P25103 1/20 0.55
TSHR P16473 1/20 0.54
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
ALDH1A1 P00352 2/20 0.53
RGS12 O14924 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TNKS2 Q9H2K2 1/20 0.52
TP53 P04637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6410759 0.83 CYP3A4 (0.83) PTK2CYP3A4CYP2C9LMNAHTT
SCHEMBL6408014 0.83 CYP3A4 (0.71) PTK2CYP3A4CYP2C9LMNAHTT
SCHEMBL6407146 0.80 PTK2 (0.69) PTK2CYP3A4CYP2C9LMNAHTT
SCHEMBL6402486 0.79 CYP3A4 (0.72) PTK2CYP3A4CYP2C9LMNAHDAC2
SCHEMBL6408279 0.77 CYP3A4 (0.80) PTK2CYP3A4CYP2C9LMNAHDAC2
SCHEMBL6404838 0.76 CYP3A4 (0.78) PTK2CYP3A4CYP2C9LMNAHTT
SCHEMBL6403236 0.75 MAPK1 (0.62) PTK2LMNAHTTMAPTTSHR
SCHEMBL21123650 0.74 TP53 (0.78) PTK2LMNAHTTHDAC2HDAC3
SCHEMBL4211759 0.74 SMN1; SMN2 (0.70) LMNAHTTMAPTTSHRMEN1
SCHEMBL6212432 0.74 LMNA (0.80) PTK2LMNAHTTMAPTTACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT PTK2 4627/4885CYP3A4 25/4885CYP2C9 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.